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Impact Statement:
•

Low birth weight (LBW) is a risk factor for adult hypercholesterolemia and increased hepatic
cholesterol.

•

Uteroplacental insufficiency (UPI) resulting in LBW increased hepatic cholesterol content,
altered hepatic expression of cholesterol metabolism-related genes in young adult guinea
pigs.

•

UPI-induced LBW was also associated with markers of a compromised hepatic cholesterol
elimination process and failing antioxidant system in young adult guinea pigs.

•

These changes, at the current age studied, were sex-specific, only being observed in LBW
males and not LBW females.

•

These programmed alterations could lead to further hepatic damage and greater
predisposition to liver diseases in UPI-induced LBW male offspring as they age.
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Abstract
Background
Intrauterine growth restriction (IUGR) and low birth weight (LBW) have been widely reported as
an independent risk factor for hypercholesterolemia and increased hepatic cholesterol underlying
liver dysfunction in adulthood. However, the specific impact of uteroplacental insufficiency (UPI),
a leading cause of LBW in developed world, on hepatic cholesterol metabolism in later life, is ill
defined and is clinically relevant in understanding later life liver metabolic health trajectories.
Methods
Hepatic cholesterol metabolism pathways were studied in uterine artery ablation-induced LBW
and normal birth weight (NBW) male and female guinea pig offspring at postnatal day 150.
Results
Hepatic free and total cholesterol were increased in LBW versus NBW males. Transcriptome
analysis of LBW versus NBW livers revealed that “Cholesterol metabolism” was an enriched
pathway in LBW males but not females. Microsomal triglyceride transfer protein and cytochrome
P450 7A1 protein, involved in hepatic cholesterol efflux and catabolism, respectively, and catalase
activity were decreased in LBW male livers. Superoxide dismutase activity was reduced in LBW
males but increased in LBW females.
Conclusions
UPI environment is associated with a later life programed hepatic cholesterol accumulation via
impaired cholesterol elimination, in a sex-specific manner. These programmed alterations could
underlie later life cholesterol-induced hepatic lipotoxicity in LBW male offspring.
Key words: low birth weight, liver, cholesterol, transcriptome, oxidative stress
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Introduction
Cholesterol, is a critical biological molecule, acting as a precursor for the synthesis of
steroid hormones, bile acids, and vitamin D, and also being critical as a central modulator of cell
membrane proteins, receptor trafficking, signal transduction, and cell membrane fluidity (1). In
mammals, the liver is the central organ regulating cholesterol homeostasis through it actions in
cholesterol uptake, export, conversion into bile acids, biosynthesis and storage (2–7). When
cholesterol homeostasis is disrupted, large concentrations of cholesterol accumulate in the liver
resulting in a lipotoxic state associated with oxidative stress and can culminate in nonalcoholic
steatohepatitis (NASH) (8–14).
An increase in the consumption of dietary cholesterol and/or genetic susceptibility to
hypercholesterolemia can underlie impaired cholesterol homeostasis, cholesterol accumulation
and a lipotoxic state in the liver (10,15,16). However, it is now becoming apparent that insults
early in the life cycle, such as in prenatal life can also contribute, in a sex-specific manner, to
aberrant cholesterol metabolism and hepatic cholesterol overload in adulthood. Animal studies
have indicated that a wide variety of experimental in utero insults/stress situations (maternal
protein undernutrition, dietary restriction, hypoxia, or prenatal nicotine), resulting in IUGR/LBW
lead to increased serum and/or hepatic cholesterol in weaned and adult male rat offspring (17–20).
Transcriptome analysis in the liver of prenatal maternal food restricted-adult rat offspring revealed
that activated cholesterol biosynthesis and downregulated bile acid biosynthesis pathways are main
targets for intrauterine programming (21). Studies have highlighted that different models yield
different outcomes and therefore, understanding in utero insult specific mechanisms is key to
identifying both conserved pathways and model-specific alterations which increase our
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understanding of how these permanent modifications in organ systems and phenotype manifest
(22,23). Collectively, this allows for better informed target interventions.
Observational human studies have reported that impaired in-utero growth and the resulting
LBW are associated with differentially increased serum concentrations of total and low density
lipoprotein (LDL) cholesterol in men and women in later life with sex difference by age groups in
adults (24–29). Although, UPI is the leading cause of IUGR/LBW in the developed world (30,31),
investigations attempting to understand the specific impact of UPI-induced IUGR/LBW on later
life hepatic cholesterol metabolism and cholesterolemia are currently limited to rat models (32,33).
New reports have begun to examine the molecular pathways that may underly the association
between abnormal fetal growth in utero and later life cholesterol metabolism dysregulation in
humans, but to date they limited to the analysis of cord blood plasma of IUGR at birth (34), with
no follow up on hepatic cholesterol metabolism and associated pathways.
In the present study, we sought to unravel the hepatic metabolic pathways underlying the
specific impact of UPI on dysregulated hepatic cholesterol metabolism in young adult female and
male LBW offspring. We have chosen to use the well-established pre-clinical animal model of
UPI-induced IUGR/LBW in guinea pigs (35), especially given the close similarities between
humans and guinea pigs with respect to hepatic and whole-body trafficking and processing of
cholesterol (36). With the use of transcriptome analysis, we postulated that LBW offspring, in a
sex-specific manner, would display increased hepatic cholesterol by young adulthood in
association with alterations in the key regulators of cholesterol metabolism.

Methods
Animals
5
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All animal procedures were conducted in accordance with guidelines and standards of the
Canadian Council on Animal Care. Animal Use Protocol (AUP-#2009-229) was approved and
post approval monitoring conducted by the Western University Animal Care Committee. All
investigators understood and followed the ethical principles outlined by Grundy (37), and study
design was informed by ARRIVE guidelines (38).
Time-mated pregnant Dunkin-Hartley guinea pigs (Charles River Laboratories,
Wilmington, MA, USA) were housed in 12 h light and dark cycles in a temperature (20 ± 2°C)
and humidity (30–40%) controlled environment, with access to guinea pig chow (LabDiet diet
5025) and tap water ad libitum. All pregnant guinea pigs underwent uterine artery ablation (35,39)
at mid-gestation (~32 days, term ~69 days) and sows delivered spontaneously. At the end of the
experimental pupping period, male and female pups were defined as normal birth weight (NBW)
or low birth (LBW) as per previously reported criteria (39,40). At weaning (postnatal day 15),
pups were housed individually in clear perplex containers, with open housing covers and wood
chew blocks, on racks allowing sound, smell and visual contact of other animals. From weaning
to young adulthood (postnatal day 150), pups were fed ad libitum a normal diet (TD.110239;
Harlan Laboratories) containing 21.6% kcal protein, 60% kcal carbohydrates and 18% kcal fat.
Animal weekly weights were recorded throughout the experiment. At postnatal day (PND) 150,
NBW (n = 8) and LBW (n = 8) offspring of each sex were fasted overnight, euthanized via CO2
inhalation (41) in the morning (~ 10 am) of the following day and tissue collection conducted. The
whole liver was removed and weighed immediately and the right lobe liver was frozen in liquid
nitrogen and stored at −80 °C for later biochemical and molecular analyses.

Hepatic biochemical analysis
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Hepatic triglycerides, total cholesterol, free cholesterol and cholesteryl ester contents were
determined with colorimetric assays. Hepatic triglycerides were measured using 50 mg of frozen
liver and following the Triglyceride Colorimetric Assay Kit (Item No. 10010303, Cayman
Chemical, Ann Arbor, Michigan, USA). Liver content of total cholesterol, free cholesterol and
cholesteryl esters was measured as previously described (42,43). Enzymatic reagents for total
cholesterol (WAKO Diagnostics: Cholesterol E (CHOD-DAOS method) #439-17501) and free
cholesterol (WAKO Diagnostics: Free cholesterol (COD-DAOS) method #435-35801) were used
as per manufacturer’s instructions. Cholesteryl ester was determined as the difference between
total cholesterol and free cholesterol.

RNA isolation
Total RNA for microarray analysis was isolated from a sub cohort of five NBW and five LBW
livers of each sex at the Genome Québec Innovation Centre (Montreal, QC) while independent
validation of microarray data was performed using RNA extracted from all NBW and LBW
animals of the experiment, including the microarray cohort. For the microarray analysis, the frozen
liver was pulverised using a mortar and pestle then 50 mg homogenized in 1 mL of Trizol
(Invitrogen, Burlington, ON, Canada). Following a 5 min incubation at room temperature, the
homogenate was treated with 100 µL of gDNA eliminator solution then shaken vigorously and
maintained at room temperature for 2-3 min. The homogenate was centrifugated at 12,000 g for
15 min at 4 °C and the upper aqueous phase transferred to a clean 2 mL safe-lock microcentrifuge
tube. RNA in the aqueous phase was then extracted using the RNeasy Plus Universal Mini Kit
(Qiagen, Toronto, ON, Canada) with the Qiacube instrument (Qiagen), following the
manufacturer’s instructions. Total RNA for validation of microarray data was isolated from frozen
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ground liver (100 mg) using Trizol reagent (Invitrogen) and the Purelink RNA Mini Kit according
to manufacturer's instructions (Invitrogen). Total RNA for both microarray analysis and validation
of microarray data was quantified using a NanoDrop Spectrophotometer 2000 (NanoDrop
Technologies, Inc., Wilmington, DE, USA). RNA integrity was assessed using a 2100 Bioanalyzer
(Agilent Technologies, Waldbronn, Germany). Only RNA with RIN > 7 were considered for the
analyses.

RNA labelling, microarray hybridization, scanning and processing
A whole-Transcript Expression Analysis Gene Titan was conducted (Genome Québec Innovation
Centre, QU, Canada). Sense-strand cDNA was synthesized from 100 ng of total RNA, and
fragmentation and labeling were performed to produce ss-cDNA with the GeneChip® WT
Terminal Labeling Kit according to manufacturer’s instructions (Thermo Fisher Scientific,
Waltham, MA, USA). After fragmentation and labeling, 2.1 µg cDNA was hybridized onto Guinea
Pig Gene 1.1 ST Array Plate (Thermo Fisher Scientific) and processed on the GeneTitan®
Instrument (Thermo Fisher Scientific) for Hyb-Wash-Scan automated workflow. The microarray
scanned images were imported into the Transcriptome Analysis Console (TAC) (version 4.0) (Life
Technologies, Carlsbad, CA, USA) and the raw microarray data (.CEL files) were normalized
using the Robust Multiple-Array Averaging (RMA) method which is implemented in the TAC
software. The RMA method converts .CEL files to .CHP and summarizes the probes into a single
signal for each probeset. Differentially expressed genes were identified using the TAC Expression
(Gene) analysis method. Microarray data have been deposited in the National Center for
Biotechnology information Gene Expression Omnibus (GEO; accession number GSE161124).

8

bioRxiv preprint doi: https://doi.org/10.1101/2020.11.12.379891; this version posted November 13, 2020. The copyright holder for this preprint
(which was not certified by peer review) is the author/funder, who has granted bioRxiv a license to display the preprint in perpetuity. It is made
available under aCC-BY-NC 4.0 International license.

Quantitative reverse transcription PCR (RT-qPCR)
Independent validation of microarray data was performed by examining levels of selected
differentially expressed transcripts using RT-qPCR. cDNA synthesis was performed with 1 μg of
total RNA using the MultiScribe™ Reverse Transcriptase Kit (Thermo Fisher Scientific). Primers
were designed from cavia porcellus sequences available in Ensembl or NCBI databases using the
NCBI/Primer-BLAST tool. Detailed information for primer sequences (forward and reverse) is
provided in Supplementary Table 1. Amplification reactions and disassociation curves of 4-fold
dilution series of cDNA were carried out on a CFX384 machine (Bio‐Rad, Bio-Rad, Mississauga,
ON), for determination of primer efficiencies. All reaction efficiencies were between 90 and 100
% with correlation coefficients of > 0.95. GAPDH and beta actin genes were simultaneously used
as internal control genes for normalization. All measurements contained a negative control (no
cDNA template). Each RNA sample was analyzed in triplicate. The 2-∆∆Ct method was used to
determine the relative expression of each transcript. The mean levels of each target transcript in
LBW were divided by mean level in NBW to indicate the fold change for comparisons to array
results.

Immunoblot analysis
Proteins were extracted from frozen ground liver (50 mg) in radioimmunoprecipitation assay
(RIPA) buffer as previously described (44). Equal amounts of total proteins (20 μg) were separated
on a 7.5 or 10% SDS-polyacrylamide gel and transferred onto PVDF membranes. Membranes
were then blocked with 5% non-fat milk in 0.1% TBS-Tween-20 and probed with primary
antibodies against Low-density lipoprotein receptor (Ldlr, MABS1208; 1:1000), fatty acid
synthase (Fas, sc-20140; 1:1000), Acetyl-CoA carboxylase (Acc, C83B10; 1/1000), Cytochrome
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P450 Family 7 subfamily A member 1 (Cyp7a1, ab65596; 1:1000), ATP binding cassette
subfamily G member 8 (Abcg8, sc-30111; 1:1000), Sterol regulatory element-binding protein 2
(Srebp2, sc-5603; 1:1000), Apolipoprotein E (Apoe, sc-98574; 1/500), Microsomal triglyceride
transfer protein (Mtp, ab63467;1:1000), Superoxide dismutase 1 (SOD1, 2770S; 1/500) and
Catalase (CAT, sc-69762; 1/500). Membranes were finally incubated with HRP-conjugated antirabbit (7074S; 1:10000; Cell Signaling Technology), anti-mouse (7076S; 1:5000, Cell Signaling
Technology). Membranes were developed using the Clarity or Clarity Max ECL substrate (BioRad). The chemiluminescence signal was captured with the ChemiDoc MP Imaging System (BioRad), and protein band densitometry was determined using the Image Lab software (Bio-Rad).
Ponceau staining was used as the loading control, as previously published (45,46).

SOD, CAT, GSH and GSSG assays
Superoxide dismutase (SOD; kit n° 706002, Cayman Chemical) and catalase (CAT; kit n° 707002,
Cayman Chemical) enzyme activities, reduced glutathione (GSH; kit n° 707002, Cayman
Chemical) and oxidized GSH (GSSG; kit n° 707002, Cayman Chemical) in livers were measured
following kit instructions. Briefly, 50 mg of ground liver were homogenized in 500 µL of sucrosemannitol buffer (70 mM sucrose, 210 mM mannitol, 20 mM HEPES and 1mM EGTA) and
centrifuged at 1, 500 × g for 5 minutes at 4°C. The SOD activities in supernatants were
subsequently measured at 450 nm and cat activities were assayed at 540 nm in diluted supernatants
(1:2000). SOD and CAT activities were expressed relative to total protein concentration for each
homogenate. For GSH and GSSG measurements, liver tissue (50 mg) was homogenised in 1 mL
of 2-(N-morpholino)ethanesulphonic acid (MES) buffer provided in the kit. The homogenate was
centrifuged at 10, 000 x g for 15 min at 4ºC and the supernatant collected. The supernatant was
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deproteinized according to the kit technical manual. The deproteinized samples were then diluted
30 times and used for total GSH (GSH+GSSG) measures. For the exclusive measurement of
GSSG, deproteinized and diluted (1:5 dilution) samples as well as standards were derivatized with
addition of 10 uL of 2-vinylpyridine 1M per mL of sample and 1h incubation at room temperature.
Total GSH and GSSG were measured at 405 nm at 5 min intervals for 30 min. GSH standard
curves from 0 to 16 μM and 0 to 8 for total gsh and gssg experiment, respectively, were employed.
The GSH was calculated by subtracting GSSG from total GSH.

Statistical analysis
Non-microarray data: A two-way ANOVA was used to determine the main effect of birth weight,
sex and possible interactions, followed by Bonferroni post hoc test using GraphPad 8 (GraphPad
Software, San Diego, CA, USA). Student's t-test was performed when appropriate. Data are
presented as mean ± SEM and a probability of 5% (P< 0.05) was considered significant for all
analyses.
Microarray data: Only genes that met the criteria of |fold change| >= 2 and p-value < 0.05 were
defined as differentially expressed. To explore biological processes and pathways associated with
the differentially expressed genes, we performed gene ontology (GO) biological process term
enrichment (adjusted P < 0.05) using human as target organism and the g:GOSt functional profiling
in g:Profiler web server (https://biit.cs.ut.ee/gprofiler/gost).

Results
Phenotypic traits
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By using diathermy partial ablation of branches of the uterine artery, UPI was induced to generate
LBW, as described previously (35). Those pups that at birth were < 85 grams, were classified as
LBW and as a group weighed less than sex-matched NBW pups (p < 0.0001; Table 1). At the time
of tissue collection (PND 150; Table 1), LBW and NBW offspring had similar mean body and
absolute and relative liver weights within each sex group. However, at this age, females displayed
overall lower body, absolute and relative liver weights than males, independent of the birth weight
(p < 0.05; Table 1). Male offspring overall exhibited higher hepatic free cholesterol and total
cholesterol than females (p < 0.05; Table 1). Interestingly, hepatic free cholesterol and total
cholesterol contents was increased in LBW males compared to NBW males (p < 0.05; Table 1).
No significant difference was observed for hepatic free cholesterol and total cholesterol content in
NBW or LBW females (Table 1). Birth weight or sex at PND 150 had no impact upon hepatic
cholesteryl ester and triglyceride contents (Table 1).

Hepatic Transcriptome
Analysis of whole hepatic transcriptome results identified that between LBW and NBW offspring
livers, 51 (29 up-regulated and 22 down-regulated) and 31 (8 up-regulated and 23 down-regulated)
genes were differentially expressed (|fold change| >= 2 and p-value < 0.05) in males and females
respectively (Fig. 1; Supplementary Tables 2 and 3). The Venn diagram (Fig. 1A), the volcano
plots (Fig. 1B, C) and 2D hierarchical clustering chart/heatmaps (Fig. 2A, B) indicate the degree
of separation among the LBW and NBW groups in males and females. Only two genes encoding
thioredoxin pseudogene and small nucleolar RNA SNORA2/SNORA34 family transcripts were
differentially expressed between LBW and NBW in both males and female offspring (Fig. 1A).
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Functional analysis of the hepatic transcriptomic profile and validation of microarray data
In the biological process analysis of the differentially expressed genes in LBW versus NBW males,
18 enriched gene ontology (GO) biological processes were observed, with positive regulation of
hepatic fatty acid metabolism process, lipid transport, lipid localization, regulation of fatty acid
biosynthetic process and positive regulation of lipid metabolic process being the five top ranked
processes (Fig. 3A, Table 2). No significant changes to GO biological processes were observed in
LBW females (Fig. 3B). The KEGG functional enrichment analysis identified that cholesterol
metabolism was a significantly enriched pathway in LBW males (adjusted p < 0.05. Fig. 3A).
Specifically, in LBW males, the reverse cholesterol transport-related genes (Apoa1 and Angplt4)
were up-regulated while Ldlr gene associated with the internalizing of circulating LDL cholesterol,
was down-regulated (Table 2, Supplementary Table 2).
The PPAR signalling pathway was also an up-regulated pathway in LBW versus NBW
offspring (adjusted p < 0.05. Fig. 3A). This latter pathway included Adipoq in addition to Apoa1
and Angplt4 (Table 2, Supplementary Table 2). FoxO signalling pathway was the only
significantly enriched pathway for differentially expressed genes in LBW females (adjusted p <
0.05. Fig. 3B). This pathway included down-regulated Bcl6 and Gadd45g (Table 2,
Supplementary Table 2).
Genes involved in cholesterol metabolism, PPAR and FoxO signalling pathways and other
differentially expressed genes not related to these pathways were selected to be validated by RTqPCR independent RNA samples (Fig. 4). Apoa1 gene was increased 4.76-fold (p = 0.037) in
LBW relative to NBW males, similar to the fold change in the microarray data of 2.92-fold (p =
0.037). Angplt4 was also confirmed to be increased by 3.7 (p = 0.023) similar to microarray fold
change of 2.84 and 1.2 (p = 0.011). In LBW versus NBW males, Ldlr and Gstt2 genes were also
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confirmed to be decreased by -2.16 and -3.05-fold (p = 0.008 and 0.020) and similar to microarray
fold changes of -2.39 and -2.44, respectively (p = 0.021 and 0.041). Inhba, which was -2.82-fold
lower in the microarray data (p = 0.036), was relatively lower in the LBW male livers by 2.89-fold
(p = 0.061). Although not significant, Anxa1, which was 2.18-fold higher in the microarray data
(p = 0.015), was relatively higher in the LBW male livers by 1.72-fold (p = 0.540). Lbp was
significantly lower by -2.28-fold in the LBW female livers in the validation cohort (p = 0.038),
similar to the -2.96-fold decreased in the LBW microarray female cohort (p = 0.026). Lastly, while
down-regulated in LBW females in the microarray data, Lcn2 and Bcl6 tended to decrease in the
validation cohort (p = 0.095 and 0.180, respectively).

Hepatic content of proteins related to cholesterol metabolism
Selected proteins were studied on a priori based on their known biological role in hepatic
cholesterol metabolism. The levels of hepatic proteins involved cholesterol uptake (Ldlr, Apoe),
biosynthesis (Srebp2), catabolism (Cyp7a1), efflux into bile acids (Abcg8) and export to blood
(Fas, Acc, Abca1 and Mtp) were determined in LBW and NBW livers (Fig. 5). Female livers
displayed significantly higher levels of Ldlr and Srebp2 protein than males (p < 0.01). Neither
birth weight nor sex impacted Apoe protein. Females displayed lower Mtp and Acc protein levels
than males (p <0.01) and Fas protein levels were not affected by birth weight nor sex. Cyp7a1 and
Mtp protein levels were both reduced in male LBW compared to male NBW livers.

Hepatic antioxidant systems
As elevated hepatic cholesterol is associated with oxidative stress (9,10), we quantified markers
of this latter. The protein levels and activities of antioxidant enzymes SOD and CAT, as well as
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GSH and GSSG concentrations were determined in LBW and NBW livers. Sex had a significant
effect on SOD1 protein level, which were lower in females than in males (p < 0.0001; Fig. 6A).
While hepatic CAT protein was not impacted by birth weight nor sex, hepatic CAT activity was
lower in male LBW (p < 0.05) (Figs. 6A, 6B). SOD activity was decreased in male LBW but
increased in female LBW. (Fig. 6C). GSH activity was not significantly affected by birth weight
or sex (Fig. 6D). While the concentration of GSSG was significantly reduced in male LBW males
compared to male NBW (p <0.05; Fig. 6E), the ratio of GSH:GSSG was not significantly impacted
by birth weight or sex (Fig. 6F).

Discussion
An adverse environment during in utero life has been associated with gene reprogramming and
modification of organ functions that can persist throughout the entire lifespan and are associated
with an increased risk of developing the metabolic syndrome (47). Using a pre-clinical guinea pig
animal model of UPI, we demonstrated that LBW is associated with increased hepatic cholesterol
content and aberrant expression of cholesterol metabolism-related signalling pathway genes in
liver. These changes occur in conjunction with markers of a compromised hepatic cholesterol
elimination process and failing antioxidant system in young adults. Interestingly, these changes,
at the current age studied, were sex-specific, only being observed in LBW males and not LBW
females.
The impact of an adverse in utero environment on cholesterol metabolism has been mostly
studied using mouse and rat models of IUGR arising from maternal protein undernutrition, in utero
dietary restriction, prenatal hypoxia, or nicotine exposure (17–20). These different species and
intrauterine insults collectively lead to elevated serum or hepatic cholesterol levels at weaning or
15
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in the adulthood in male offspring, similar to what was observed in this current study. The specific
etiology of the IUGR insult is of critical importance in determining the adult metabolic outcomes
and phenotype (22,23) and hence in the current study, UPI was investigated as it is the most
common in utero insult associated with IUGR and LBW in developed world (48,49). Moreover,
the guinea pig was utilized given its greater similarities with human pregnancy and outcomes
including a relatively long gestation, haemomonochorial placenta, luteo‐placental shift in hormone
production, fetal development of metabolic tissues and precocial offspring (50). The reported
outcomes here are similar to the observed increased in blood total cholesterol at 15 weeks of age
observed in UPI-induced IUGR male rat offspring (51). Additionally, the observed increase in
hepatic cholesterol without increased hepatic triglycerides in male LBW offspring is also in
alignment with other species studies that report IUGR-induced alterations in the cholesterol
metabolizing pathway, without changes in hepatic fatty acid metabolism (33). The current work
highlights not only that the UPI environment is associated with programming of later life hepatic
cholesterol dysfunction, but also validates the experimental in utero insults/stress situations used
in other species. Collectively, this provides external validation for the central nature of this
pathway and later life cholesterol metabolism dysregulation across species.
The present study also highlights that cholesterol metabolism and PPAR signalling
pathways are impacted and associated genes are differentially expressed in LBW versus NBW
male offspring, but not in females. Hepatic Apoa1, Angplt4 and Adipoq genes, components of both
cholesterol metabolism and PPAR pathways were up-regulated exclusively in LBW males. Apoa1
is the main apolipoprotein of HDL, playing a key role in regulating lipid transport and in the
process of reverse cholesterol transport acting through promotion of the efflux of excess
cholesterol from peripheral tissues and returning it to the liver for biliary excretion (52). Liver
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ApoA-1 gene expression is up-regulated in liver disease states (53,54), and ApoA-1 protein among
other liver-specific proteins in extracellular vesicles, has been suggested to potentially serve as a
specific biomarker for hepatotoxicity in drug- and alcohol-mediated hepatic injury (55).
Additionally, Angptl4 and Adipoq, like ApoA-1, collectively serve a number of important roles in
cholesterol metabolism. Angptl4 is present in HDLs physically protecting HDLs from endothelial
lipase hydrolysis (56), and upregulates cholesterol synthesis in liver secondary to inhibition of
lipoprotein lipase- and hepatic lipase-dependent hepatic cholesterol uptake (57). In addition,
Adipoq accelerates reverse cholesterol transport by increasing HDL assembly through enhanced
ApoA-1 synthesis in the liver (58). Conversely, the decreased Ldlr gene expression and unaltered
Ldlr protein in LBW males may reflect an unaltered LDL cholesterol uptake into these livers. In
agreement with this assumption, it is well established that over-accumulation of cholesterol in the
liver supresses Ldlr gene transcription and accelerates its mRNA decay (59). Finally, the
intersection of cholesterol and PPAR pathways is of note given the relationship between PPARs
in the regulation of pathways in bile acid and cholesterol homeostasis (60). Therefore, the current
changes in gene expression collectively emphasize potential increased HDL assembly and/or
reverse cholesterol transport, in conjunction with an unaltered LDL uptake in the LBW male livers,
which elucidates the higher cholesterol content observed in these livers, though this remain to be
more thoroughly investigated.
Although unaltered at transcriptional level, hepatic Cyp7a1 and Mtp was significantly
reduced at the protein level in LBW males. The Cyp7a1 enzyme catalyzes the initial step in
cholesterol catabolism and bile acid synthesis and decreased Cyp7a1 gene expression and protein
levels have been reported in conjunction with increased hepatic cholesterol in adult IUGR male
rats from protein restricted mothers (17). Further, Cyp7a1 deficient mice are observed to have
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elevated hepatic and serum cholesterol and decreased total bile acids (61), supporting the concept
that Cyp7A1 acts in a similar manner in guinea pigs and rats and that alterations in its level/activity
impact hepatic cholesterol content. It is of further interest to note that the human CYP7A1 mutation
results in substantial cholesterol accumulation in the liver as well as decreased classic bile acid
synthesis (62). Our current findings are in line with the concept that Cypa7a1 is critical in the
control of hepatic cholesterol homeostasis and provide evidence that Cyp7a1-induced cholesterol
catabolism appears sensitive to changes in the intrauterine environment, specifically those
associated with UPI such as hypoxia and altered nutrient supply (17,19). The parallel decrease in
Mtp protein is of great interest considering that Mtp catalyses the assembly of cholesterol,
triglycerides, and apolipoprotein B to VLDL for their export outside of the liver (63). Therefore,
this impairment in hepatic cholesterol catabolism/efflux-related proteins could reflect a lower
elimination rate of hepatic cholesterol, programmed by an adverse in utero environment, which
culminates in increased cholesterol content in LBW males born from pregnancies complicated by
UPI.
Antioxidant enzyme defense and non-enzymatic antioxidant defense systems are critical in
reducing oxidative stress and maintaining redox homeostasis within liver (64). SOD reduces the
radical superoxide to form hydrogen peroxide and oxygen (65) and CAT catalytically decomposes
hydrogen peroxide into water and oxygen (66). At the same time, glutathione peroxidase (GPx)
also reduces hydrogen peroxide to water while converting GSH to GSSG (67). During oxidative
stress there is decrease in levels of GSH and increase in levels of GSSG and thus GSH/GSSG ratio
decreases (68). Liver oxidative injury and abnormal activities of hepatic antioxidant enzymes are
reported in male neonates from IUGR pregnancies (69,70). In the current report, UPI-induced
LBW male offspring displayed a significantly depressed CAT activity, and a reduced total SOD
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activity, a result not observed in the LBW female livers. The ratio of GSH to GSSG was however
not reduced in the livers of LBW males. Collectively, these data suggest that whereas female
offspring appear to have functional postnatal hepatic oxidative stress recovery mechanisms, the in
utero defects in male offspring appear to persist, and this could be manifest with the altered hepatic
cholesterol metabolic pathways observed. Indeed, in adult animal cholesterol feeding studies,
elevated hepatic cholesterol is associated with oxidative stress (9,10). It is then possible that
alterations in the functional postnatal hepatic oxidative stress of male LBW start at the level of
SOD and CAT enzymes and may later extend to the glutathione redox couple GSH/GSSG system,
as previously highlighted (68). This notion is further validated by the observed reduction in the
expression of inhba and Gstt2 genes, involved in hepatocyte regeneration and antioxidant system,
respectively (71,72). Therefore, our current observations point to a lower antioxidant capacity in
young adult LBW male offspring born from UPI pregnancies, which may promote the
development of liver diseases in later life, especially when challenged with an elevated cholesterol
environment.
In the current study, we observed lower body and liver weights at young adulthood in
females than males, independent of the birth weight. Previous studies have also reported a sexual
dimorphism in guinea pig with males consistently larger than females in skeletal measurements
and body weight (73,74). It has been proposed that rapid and early growth in males leads to malebiased sexual dimorphism in these cases. In conjunction with these growth differences we report
sexual dimorphism in hepatic Ldlr, Srebp2, Mtp, Acc and SOD1 proteins as well as liver
cholesterol content, irrespective of birth weight, but also sex-specific programming of Apoa1,
Angplt4, and ldlr genes and Cyp7a1 and Mtp proteins in male LBW offspring. Epidemiologic
studies have demonstrated that LBW predisposes to adult onset hypercholesterolemia in men (26–
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28), and women (29) with sex difference by age groups in adults (24). In the current study, male
offspring displayed higher hepatic free cholesterol and total cholesterol than females, despite
higher protein abundance of Ldlr and Srebp2 and reduced Mtp and Acc proteins in female livers.
We speculate that estrogens levels may be protective for cholesterol overaccumulation within
livers of female guinea pigs, given that physiological levels of estrogen increased CYP7A1 activity
along with small transient increases in BA production in hepatocytes (75). These results also
indicate that such a protective mechanism may occur as a compensatory mechanism to higher
protein level of Ldlr and Srebp2 in males and reduced Mtp and Acc proteins in females. It was
interesting to note also the sex-specific difference observed in Lcn2 and Bcl6 in female LBW.
These genes are involved in alleviating and promoting hepatic lipotoxicity, respectively (76,77),
and their down-regulation in female LBW may underly a tight regulation of lipid catabolism in
these offspring given their unaltered hepatic triglycerides and cholesterol contents.
The present study demonstrates that LBW occurring as a result of UPI results in increased
hepatic cholesterol content, likely through compromised hepatic cholesterol elimination- in young
male, but not female guinea pigs. The mechanisms underlying this potential programing effect and
continued postnatal presentation of the defect are yet to be fully delineated. Certainly UPI is
associated with hypoxia (78) and fetal hypoxia is associated with promoted oxygenated blood flow
to the heart and reduced umbilical blood supply to fetal liver, an adaption which is understood to
reprogram liver carbohydrate and lipid metabolism in utero (79–82) likely through altered
epigenetic regulation of hepatic metabolism (17). Furthermore, the observed disrupted hepatic
cholesterol metabolism may contribute to permanent alterations in hepatic oxidative stress defense
system, ultimately leading to further hepatic damage and greater predisposition to liver diseases in
UPI-induced LBW male offspring as they age.
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FIGURE LEGENDS

Fig. 1: Differential gene analysis, volcano plots and hierarchical clustering chart/heat maps.
(A) Venn diagram demonstrating differentially up- and down-regulated genes in 5 NBW versus 5
LBW offspring using Transcriptome Analysis Console (TAC) Software at a |fold change| >= 2 and
p-value < 0.05. Volcano plots were generated to visualize the differentially expressed genes
(DEGs) between LBW and NBW in males (B) and females (C). The x-axis indicates the
fold-change and the y-axis represents the log10 p-values. The orange and red points indicate the
up-regulated and down-regulated mRNAs with statistical significance, respectively.

Fig. 2: Heat map looking at differential changes of genes. Hierarchical clustered heat maps of
DEGs between LBW and NBW in males (A) and females (B). Each column represents one sample
and Value to the right of colour scale indicates the (log2) gene expression. The intensity of the
colour indicates the expression level, with black representing a high expression level and orange
representing a low expression level. Gene symbols are indicated on the right of the heat maps.

Fig. 3: Gene function analysis. Manhattan plots illustrate the enrichment analysis results on
DEGs between LBW and NBW in males (A) and females (B). The x-axis represents functional
terms that are grouped and colour-coded by data sources (e.g. biological processes (BP) from gene
ontology (GO) are orange circles and enriched KEGG pathways are purple circles). The circle
sizes are in accordance with the corresponding term size, i.e. larger terms have larger circles. The
y-axis shows the adjusted enrichment p-values in negative log10 scale.
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Fig. 4: RT-qPCR validation for selected differentially expressed genes. Transcriptomic
differences between NBW and LBW in males (A) and females (B) were evaluated by RT-qPCR.
RT-qPCR fold change values are the ratios of LBW to NBW; ratios are inversed and preceded by
a minus sign for value less than 1 (i.e., a ratio of 0.5 is expressed as -2). n = 7-8 samples per group.
Data are mean ± SEM. *p < 0.05 and **p < 0,01 using Student t-test for independent samples.

Fig. 5: Immunoblotting for proteins related to cholesterol metabolism. Panel A shows
representative blots of the targeted proteins and ponceau S as a loading control. Panel B indicates
normalized densitometry values (targeted protein: ponceau) of targeted proteins. Data are mean ±
SEM of 6 to 7 animals per birth weight/sex group. $$p <0.01 and $$$$p < 0.0001 for the main effect
of sex, #p <0.05 for the main effect of birth weight, using a two-way ANOVA. *p < 0.05 when
comparing NBW/Males vs. LBW/Males by Bonferroni post hoc test.

Fig.6: Immunoblotting and colorimetric assays of antioxidant system. Panel A shows
representative blots of Catalase (CAT) and superoxide dismutase 1 (SOD1) proteins and ponceau
as well as normalized densitometry values of targeted proteins. Panel B shows hepatic activity of
catalase (CAT) and Panel C indicates hepatic activity of superoxide dismutase activity (SOD).
Panels D, E and F show reduced glutathione (GSH), oxidized GSH (GSSG) and GSH/GSSG ratio,
respectively. Data means ± SEM of 7 to 8 animals per birth weight/sex group. $$$$p < 0.0001 for
the main effect of sex; #p < 0.05 or the indicated p- value for the main effect of birth weight (BW)
and ϕp < 0.05 for the effect BW and sex interaction, using a two-way ANOVA. *p < 0.05 when
comparing NBW/Males vs. LBW/Males by Bonferroni post hoc test.
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Table 1: Phenotypic traits of the offspring
Males
Oxylipin
Birth weight
(BW; g)
Body weight at
postnatal day
(PND)150 (g)

Females

p-value

NBW

LBW

NBW

LBW

BW

Sex (S)

BW × S

110.43±2.56

79.04±1.30****

105.75±4.28

69.50±2.81****

<0.001

0.022

0.415

737.75±32.57

652.75±27.25

5.99.86±33.04

0.111

<0.001

0.872

802.20±46.63

Liver weight at
PND150 (g)

30.85±2.27

28.85±2.17

20.90±1.30

19.78±0.94

0.393

<0.001

0.807

Liver: body
weight ratio

0.039 ± 0.00

0.040 ± 0.00

0.032 ± 0.00

0.033 ± 0.00

0.651

0.014

0.952

Free cholesterol
(mg/g wet liver)

2.48 ± 0.13

3.05 ± 0.18*

1.89 ± 0.17

2.30±0.19

0.007

<0.001

0.640

Cholesteryl ester
(mg/g wet liver)

0.43±0.06

0.74±0.17

0.58±0.17

0.65±0.13

0.174

0.827

0.402

Total cholesterol
(mg/g wet liver)

2.90±0.13

3.79±0.29*

2.44±0.32

2.96±0.27

0.012

0.020

0.485

Triglycerides
(mg/g wet liver)

0.03±0.00

0.04±0.01

0.03±0.01

0.04±0.01

0.143

0.721

0.896

Birth weight, body and liver weights at postnatal day 150, hepatic content of different cholesterol types and triglycerides were determined
in male and female offspring at postnatal day 150. n = 8 NBW and 8 LBW for each sex group. Data are mean ± SEM. The main effect
of birth weight (BW), sex and BW and sex interaction, using a two-way ANOVA, are displayed. *p < 0.05, ****p < 0.0001 when
comparing NBW/Males versus. LBW/Males or NBW/females versus. LBW/females by Bonferroni post hoc test.

Table 2. Gene ontology (GO) terms and KEGG pathways overrepresented among differentially expressed genes in livers of LBW
versus NBW offspring
Sex

Male

Female

Source

Term name

GO:BP
GO:BP
GO:BP
GO:BP
GO:BP
GO:BP
GO:BP
GO:BP
GO:BP
GO:BP
GO:BP
GO:BP
GO:BP
GO:BP
GO:BP
GO:BP
GO:BP
GO:BP

Positive regulation of fatty acid metabolic process 0.0001
Lipid transport
0.0003
Lipid localization
0.0006
Regulation of fatty acid biosynthetic process
0.0009
Positive regulation of lipid metabolic process
0.0015
Regulation of multicellular organismal development 0.0022
Positive regulation of fatty acid biosynthetic process 0.0036
Positive regulation of lipid biosynthetic process
0.0053
Regulation of fatty acid metabolic process
0.0067
Regulation of lipid biosynthetic process
0.0071
Regulation of lipid metabolic process
0.0157
Regulation of developmental process
0.0250
Positive regulation of small molecule metabolic process
0.0285
Regulation of cell differentiation
0.0332
Cell development
0.0343
Negative regulation of macrophage differentiation
0.0365
Cell differentiation
0.0423
Regulation of cell development
0.0492

Adjusted p value

Genes
Mid1ip1,Anxa1,Adipoq,Apoa1
Inhba,Ldlr,Mid1ip1,Anxa1,Ace,Adipoq,Apoa1
Inhba,Ldlr,Mid1ip1,Anxa1,Ace,Adipoq,Apoa1
Mid1ip1,Anxa1,Adioq,Apoa1
Ldlr,Mid1ip1,Anxa1,Adipoq,Apoa1
Inhba,Serpine2,Ldlr,Nell1,Nedd4l,Anxa1,Ace,Angptl4,Adipoq,Apoa1,Hey1,Nrep
Mid1ip1,Anxa1,Apoa1
Ldlr,Mid1ip1,Anxa1,Apoa1
Mid1ip1,Anxa1,Adipoq,Apoa1
Ldlr,Mid1ip1,Anxa1,Adipoq,Apoa1
Ldlr,Mid1ip1,Anxa1,Angptl4,Adipoq,Apoa1
Inhba,Serpine2,Ldlr,Nell1,Nedd4l,Anxa1,Ace,Angptl4,Adipoq,Apoa1,Hey1,Nrep
Mid1ip1,Anxa1,Adipoq,Apoa1
Inhba,Serpine2,Ldlr,Nell1,Nedd4l,Anxa1,Adipoq,Apoa1,Hey1,Nrep
Inhba,Serpine2,Inhbe,Ldlr,Nedd4l,Tubb3,Adipoq,Apoa1,Hey1,Nrep
Inhba,Adipoq
Inhba,Serpine2,Inhbe,Ldlr,Krtap12-1,Nell1,Nedd4l,Tubb3,Anxa1,Ace,Adipoq,Apoa1,Hey1,Nrep
Serpine2,Ldlr,Nedd4l,Adipoq,Apoa1,Hey1,Nrep

KEGG pathway Cholesterol metabolism
KEGG pathway PPAR signaling pathway

0.0080
0.0277

Ldlr,Angptl4,Apoa1
Angptl4,Adipoq,Apoa1

KEGG pathway FoxO signaling pathway

0.0366

Bcl6,Gadd45g

Fig. 1
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